PPARγ has been proposed as a therapeutic target in thyroid cancer [76], but although attempts have been made to correlate PPARγ expression with miR-27a, as yet there is no firm evidence linking miRNAs and PPARs in this type of cancer [77]. This evidence concerns the gene PPARG and cancer.